Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · IEX Real-Time Price · USD
3.170
+0.230 (7.82%)
At close: Jul 2, 2024, 4:00 PM
3.090
-0.080 (-2.52%)
After-hours: Jul 2, 2024, 4:24 PM EDT
Tenax Therapeutics Stock Forecast
TENX's stock price has decreased by -87.01% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Tenax Therapeutics stock has a target of 30, which predicts an increase of 846.37% from the current stock price of 3.17.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 20, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for TENX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +846.37% | Feb 20, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $480 | Strong Buy | Reiterates | $480 | +15,041.96% | Nov 13, 2023 |
| Roth MKM | Roth MKM | Strong Buy Initiates $480 | Strong Buy | Initiates | $480 | +15,041.96% | Mar 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $8,000 | Strong Buy | Initiates | $8,000 | +252,265.93% | Dec 29, 2020 |
| Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | May 18, 2017 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-8.11
from -31.04
EPS Next Year
-3.79
from -8.11
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 8.7M | 147.4M | 263.1M |
| Avg | n/a | n/a | 4.2M | 143.2M | 255.6M |
| Low | n/a | n/a | n/a | 137.6M | 245.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 3,376.2% | 83.8% |
| Avg | - | - | - | 3,276.9% | 78.5% |
| Low | - | - | - | 3,144.3% | 71.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -8.12 | -2.04 | -1.43 | 15.80 | 23.47 |
| Avg | -8.11 | -3.79 | -2.88 | 15.35 | 22.80 |
| Low | -8.02 | -5.38 | -4.20 | 14.75 | 21.90 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 52.9% |
| Avg | - | - | - | - | 48.5% |
| Low | - | - | - | - | 42.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.